Publicacions en què col·labora amb JUAN ANTONIO MARCHAL CORRALES (42)

2024

  1. Identification of novel biomarkers in the early diagnosis of malignant melanoma by untargeted liquid chromatography coupled to high-resolution mass spectrometry-based metabolomics: a pilot study

    British Journal of Dermatology, Vol. 190, Núm. 5, pp. 740-750

2023

  1. Interferon-Alpha Decreases Cancer Stem Cell Properties and Modulates Exosomes in Malignant Melanoma

    Cancers, Vol. 15, Núm. 14

  2. Lentiviral vectors for inducible, transactivator-free advanced therapy medicinal products: Application to CAR-T cells

    Molecular Therapy - Nucleic Acids, Vol. 32, pp. 322-339

  3. TGFβ Governs the Pleiotropic Activity of NDRG1 in Triple-Negative Breast Cancer Progression

    International Journal of Biological Sciences, Vol. 19, Núm. 1, pp. 204-224

2022

  1. Nanomedicine as a Promising Tool to Overcome Immune Escape in Breast Cancer

    Pharmaceutics, Vol. 14, Núm. 3

  2. Physiological lentiviral vectors for the generation of improved CAR-T cells

    Molecular Therapy - Oncolytics, Vol. 25, pp. 335-349

  3. The p38 MAPK Components and Modulators as Biomarkers and Molecular Targets in Cancer

    International Journal of Molecular Sciences, Vol. 23, Núm. 1

2021

  1. Anti-CD44-Conjugated Olive Oil Liquid Nanocapsules for Targeting Pancreatic Cancer Stem Cells

    Biomacromolecules, Vol. 22, Núm. 4, pp. 1374-1388

  2. Antioxidants for the treatment of breast cancer: Are we there yet?

    Antioxidants, Vol. 10, Núm. 2, pp. 1-44

  3. Exosomes: Their role in pathogenesis, diagnosis and treatment of diseases

    Cancers, Vol. 13, Núm. 1, pp. 1-45

  4. Improved functionality of integration-deficient lentiviral vectors (IDLVs) by the inclusion of IS2 protein docks

    Pharmaceutics, Vol. 13, Núm. 8

  5. Metabolomic profile of cancer stem cell-derived exosomes from patients with malignant melanoma

    Molecular Oncology, Vol. 15, Núm. 2, pp. 407-428

  6. The p38 MAPK Components and Modulators as Biomarkers and Molecular Targets in Cancer

    International journal of molecular sciences, Vol. 23, Núm. 1

2020

  1. Exosome: A new player in translational nanomedicine

    Journal of Clinical Medicine, Vol. 9, Núm. 8, pp. 1-27

  2. Uncovering tumour heterogeneity through PKR and nc886 analysis in metastatic colon cancer patients treated with 5-FU-based chemotherapy

    Cancers, Vol. 12, Núm. 2

2019

  1. Melanoma cancer stem-like cells: Optimization method for culture, enrichment and maintenance

    Tissue and Cell, Vol. 60, pp. 48-59

  2. Pancreatic (pro)enzymes treatment suppresses BXPC-3 pancreatic Cancer Stem Cell subpopulation and impairs tumour engrafting

    Scientific Reports, Vol. 9, Núm. 1

2018

  1. Activating transcription factor 4 modulates TGFb-induced aggressiveness in triple-negative breast cancer via SMad2/3/4 and mTORC2 signaling

    Clinical Cancer Research, Vol. 24, Núm. 22, pp. 5697-5709

  2. Mesenchymal stem cell's secretome promotes selective enrichment of cancer stem-like cells with specific cytogenetic profile

    Cancer Letters, Vol. 429, pp. 78-88

2017

  1. 1-(Benzenesulfonyl)-1,5-dihydro-4,1-benzoxazepine as a new scaffold for the design of antitumor compounds

    Future Medicinal Chemistry, Vol. 9, Núm. 11, pp. 1129-1140